🇺🇸 FDA

Company profile · Sponsor

Ignis

Ignis Therapeutics (Suzhou) Limited

C52692B · NMPA pharma CN
Pipeline
1
Drugs
0
Patents
0

Quick answer

Ignis (C52692B) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C52692B
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (1)

Search pipeline →

  1. Solriamfetol

    Ignis

    Sleep Apnea, Obstructive

    phase 3 small molecule completed

    1 trial

Frequently asked questions

What is Ignis?

Ignis (C52692B) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Ignis sponsor?

We track 1 ClinicalTrials.gov-linked program for Ignis, including Solriamfetol. Open each program for phase, modality, NCT IDs, and indication details.

Where does Ignis company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.